tiprankstipranks
Kanoria Chemicals & Industries Ltd (IN:KANORICHEM)
:KANORICHEM
India Market

Kanoria Chemicals & Industries Ltd (KANORICHEM) AI Stock Analysis

1 Followers

Top Page

IN:KANORICHEM

Kanoria Chemicals & Industries Ltd

(KANORICHEM)

Select Model
Select Model
Select Model
Neutral 45 (OpenAI - 5.2)
Rating:45Neutral
Price Target:
₹67.00
▼(-13.12% Downside)
Action:ReiteratedDate:12/13/25
Kanoria Chemicals & Industries Ltd faces significant financial challenges, with persistent net losses and increasing debt levels being the most impactful factors. Technical analysis indicates a bearish trend, and valuation metrics suggest potential overvaluation. The absence of earnings call data and corporate events means these factors do not influence the score. Overall, the stock presents moderate risk, requiring strategic improvements for better financial health.
Positive Factors
Diversified end markets
Serving a broad set of downstream industries spreads demand risk and reduces exposure to any single cyclical sector. Over a 2-6 month horizon this diversification helps stabilize sales volumes and revenue variability, providing durable demand buffers across industry cycles.
Negative Factors
Persistent net losses
Ongoing net losses erode retained earnings and constrain the company’s ability to self-finance growth or absorb shocks. Over a multi-month horizon, persistent losses pressure liquidity, hurt return metrics and require clear operational turnaround or external capital to restore financial health.
Read all positive and negative factors
Positive Factors
Negative Factors
Diversified end markets
Serving a broad set of downstream industries spreads demand risk and reduces exposure to any single cyclical sector. Over a 2-6 month horizon this diversification helps stabilize sales volumes and revenue variability, providing durable demand buffers across industry cycles.
Read all positive factors

Kanoria Chemicals & Industries Ltd (KANORICHEM) vs. iShares MSCI India ETF (INDA)

Kanoria Chemicals & Industries Ltd Business Overview & Revenue Model

Company Description
Kanoria Chemicals & Industries Limited manufactures and sells chemical intermediates in India. The company operates through Alco Chemicals and Solar Power segments. It provides chemicals, such as acetaldehyde, di-pentaerythritol, formaldehyde, hex...
How the Company Makes Money
Kanoria Chemicals & Industries Ltd primarily makes money by manufacturing and selling chemical products to industrial customers. Key revenue streams: 1) Sale of aliphatic amines: The company produces and sells aliphatic amines (specialty/industri...

Kanoria Chemicals & Industries Ltd Financial Statement Overview

Summary
Kanoria Chemicals & Industries Ltd is facing financial challenges characterized by fluctuating revenues, persistent net losses, and increasing debt levels. While there are signs of operational improvement, the company must focus on enhancing profitability, reducing leverage, and improving cash flows to ensure long-term financial health. The current financial position indicates moderate risk, requiring strategic management actions to stabilize performance.
Income Statement
45
Neutral
Balance Sheet
50
Neutral
Cash Flow
40
Negative
BreakdownTTMMar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Income Statement
Total Revenue14.43B15.37B14.75B15.78B13.69B10.95B
Gross Profit4.13B4.71B4.67B4.62B3.86B3.44B
EBITDA463.20M106.12M642.63M826.90M955.19M991.32M
Net Income-649.00M-836.00M-383.96M-87.70M68.26M145.23M
Balance Sheet
Total Assets11.08B14.98B14.90B14.81B14.03B13.62B
Cash, Cash Equivalents and Short-Term Investments460.30M109.60M141.07M308.20M314.68M348.06M
Total Debt3.27B5.95B5.09B5.10B4.75B4.93B
Total Liabilities5.77B9.88B8.73B8.74B8.01B7.66B
Stockholders Equity5.31B5.21B6.01B6.05B5.98B5.87B
Cash Flow
Free Cash Flow-249.90M-800.10M-432.20M-317.60M402.19M548.15M
Operating Cash Flow77.10M202.80M375.70M257.20M830.76M824.60M
Investing Cash Flow-242.20M-648.70M-503.50M-249.80M-431.08M-118.15M
Financing Cash Flow571.80M414.60M51.40M34.49M-530.48M-749.09M

Kanoria Chemicals & Industries Ltd Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price77.12
Price Trends
50DMA
68.25
Positive
100DMA
71.43
Negative
200DMA
78.62
Negative
Market Momentum
MACD
0.11
Negative
RSI
57.34
Neutral
STOCH
85.02
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:KANORICHEM, the sentiment is Neutral. The current price of 77.12 is above the 20-day moving average (MA) of 63.09, above the 50-day MA of 68.25, and below the 200-day MA of 78.62, indicating a neutral trend. The MACD of 0.11 indicates Negative momentum. The RSI at 57.34 is Neutral, neither overbought nor oversold. The STOCH value of 85.02 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for IN:KANORICHEM.

Kanoria Chemicals & Industries Ltd Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
64
Neutral
₹1.66B15.66
64
Neutral
₹1.11B18.7110.99%-76.65%-76.77%
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
61
Neutral
₹15.53B215.6111.83%124.74%
54
Neutral
₹3.85B23.3339.31%
45
Neutral
₹2.99B23.83-1.30%-27.85%
43
Neutral
₹2.53B-19.090.38%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IN:KANORICHEM
Kanoria Chemicals & Industries Ltd
70.01
-13.30
-15.96%
IN:CENTEXT
Century Extrusions Ltd
20.76
2.24
12.10%
IN:DIAMINESQ
Diamines & Chemicals Ltd.
258.25
-59.88
-18.82%
IN:LORDSCHLO
Lords Chloro Alkali Limited
153.15
12.65
9.00%
IN:MAHASTEEL
Mahamaya Steel Industries Ltd.
944.90
699.85
285.59%
IN:OCCL
Oriental Carbon & Chemicals Ltd
110.78
-62.62
-36.11%

Kanoria Chemicals & Industries Ltd Corporate Events

Kanoria Chemicals Shareholders Approve Hike in Authorised Capital at EGM
Apr 2, 2026
Kanoria Chemicals Industries Ltd has disclosed the voting results of its extraordinary general meeting held on 1 April 2026, where shareholders considered a special resolution to increase the company’s authorised share capital and amend its...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Dec 13, 2025